This author has yet to write their bio.Meanwhile lets just say that we are proud Reuters Health contributed a whooping 7357 entries.
A pensioner sits in a residential home for the elderly in Emmenbruecke near Lucerne December 7, 2007. Reuters/Christian Hartmann <span class="articleLocation”>(Reuters Health) – Whether it is cause or effect is […]
(Reuters) – U.S. drugmaker AbbVie Inc reported better-than-expected quarterly profit and revenue, driven by strong sales of its arthritis drug, Humira. Shares of the company, which also raised its full-year […]
(Reuters) – A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body’s immune system to kill cancer cells. The partnership […]
(Reuters) – Swiss drugmaker Novartis (NOVN.VX) beat first-quarter profit forecasts on Thursday, defying the impact of a strong dollar thanks to surprisingly strong margins. The Basel-based group confirmed its guidance […]
(Reuters) – Eli Lilly and Co (LLY.N) soundly beat quarterly profit estimates on lower-than-expected spending on research and marketing, but revenue slipped as the stronger dollar hurt sales outside the […]
A woman holds her stomach at the last stages of her pregnancy in Bordeaux April 28, 2010. Reuters/Regis Duvignau (Reuters Health) – Children born to women who suffered severe nausea […]
<span class=”articleLocatio n”>(Reuters) – Boehringer Ingelheim Pharmaceuticals Inc said its emergency blood clotting agent was granted a priority review status by the U.S. Food and Drug Administration, accelerating the […]
(Reuters) – A federal judge on Wednesday gave final approval to a multimillion-dollar settlement in a lawsuit brought by about 5,000 former National Football League players who accused the league […]
(Reuters) – Swiss drugmaker Roche has “renewed confidence” that drugs targeting potentially brain-destroying plaque can fight Alzheimer’s disease, following promising results with a product from a rival. Pharmaceuticals head Daniel […]
(Reuters) – Novo Nordisk has launched its Saxenda obesity drug in the United States, it said on Wednesday, a long-awaited milestone that will provide a new revenue stream for the […]
